156 related articles for article (PubMed ID: 15453342)
21. Entecavir surprise.
Hirsch MS
N Engl J Med; 2007 Jun; 356(25):2641-3. PubMed ID: 17582076
[No Abstract] [Full Text] [Related]
22. [Comparison of the therapeutical effects of entecavir and lamvudine in treatment of HBeAg-positive chronic hepatitis B].
Hou HB; Deng LN; Li CP; Liu XR; Liu FQ
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):873-4. PubMed ID: 19958652
[No Abstract] [Full Text] [Related]
23. Antiviral therapy of chronic hepatitis B.
Zoulim F
Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
[TBL] [Abstract][Full Text] [Related]
24. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.
Lai CL; Shouval D; Lok AS; Chang TT; Cheinquer H; Goodman Z; DeHertogh D; Wilber R; Zink RC; Cross A; Colonno R; Fernandes L;
N Engl J Med; 2006 Mar; 354(10):1011-20. PubMed ID: 16525138
[TBL] [Abstract][Full Text] [Related]
25. Looking to the future: new agents for chronic hepatitis B.
Dienstag JL
Am J Gastroenterol; 2006; 101 Suppl 1():S19-25. PubMed ID: 16448448
[TBL] [Abstract][Full Text] [Related]
26. [Entecavir--close perspective for using it].
Halota W; Pawłowska M
Przegl Epidemiol; 2006; 60(1):115-8. PubMed ID: 16758749
[TBL] [Abstract][Full Text] [Related]
27. [Entecavir. Treatment of chronic hepatitis b virus infections].
Musch A
Med Monatsschr Pharm; 2006 Nov; 29(11):392-6. PubMed ID: 17131685
[No Abstract] [Full Text] [Related]
28. [Long-term entecavir efficacy retention in the treatment of chronic hepatitis B with an outcome to hepatic cirrhosis caused by its resistant virus strain].
Znoiko OO; Dudina KR; Safiullina NKh; Karandashova IV; Chulanov VP
Ter Arkh; 2012; 84(11):61-3. PubMed ID: 23252250
[TBL] [Abstract][Full Text] [Related]
29. Entecavir resistance is rare in nucleoside naïve patients with hepatitis B.
Colonno RJ; Rose R; Baldick CJ; Levine S; Pokornowski K; Yu CF; Walsh A; Fang J; Hsu M; Mazzucco C; Eggers B; Zhang S; Plym M; Klesczewski K; Tenney DJ
Hepatology; 2006 Dec; 44(6):1656-65. PubMed ID: 17133475
[TBL] [Abstract][Full Text] [Related]
30. [Chronic HBeAg-negative viral gepatitis B: treatment is essential and possible].
Isakov VA
Eksp Klin Gastroenterol; 2007; (5):40-5. PubMed ID: 18389596
[No Abstract] [Full Text] [Related]
31. [Results of 3 years of continuous entecavir treatment in nucleos(t)ide-naive chronic hepatitis B patients].
Yao GB; Ren H; Xu DZ; Zhou XQ; Jia JD; Wang YM; Chen CW
Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):881-6. PubMed ID: 20038326
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection.
Zoulim F
Antiviral Res; 2004 Oct; 64(1):1-15. PubMed ID: 15451174
[TBL] [Abstract][Full Text] [Related]
33. Chronic hepatitis B infection in pregnancy illustrated by a case of successful treatment with entecavir.
Kakogawa J; Sakurabashi A; Sadatsuki M; Gomibuchi H; Minoura S
Arch Gynecol Obstet; 2011 Dec; 284(6):1595-6. PubMed ID: 21861151
[No Abstract] [Full Text] [Related]
34. [The effect of entecavir treatment on HBV-specific immunity in patient with chronic hepatitis B and its relationship to HBeAg sero-conversion].
Li JX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):122-3. PubMed ID: 18574534
[TBL] [Abstract][Full Text] [Related]
35. Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.
Lai CL; Rosmawati M; Lao J; Van Vlierberghe H; Anderson FH; Thomas N; Dehertogh D
Gastroenterology; 2002 Dec; 123(6):1831-8. PubMed ID: 12454840
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B--preventable and now treatable.
Hoofnagle JH
N Engl J Med; 2006 Mar; 354(10):1074-6. PubMed ID: 16525145
[No Abstract] [Full Text] [Related]
37. One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levels.
Wong DK; Yuen MF; Ngai VW; Fung J; Lai CL
Antivir Ther; 2006; 11(7):909-16. PubMed ID: 17302253
[TBL] [Abstract][Full Text] [Related]
38. Entecavir for chronic hepatitis B: a review.
Palumbo E
Ther Drug Monit; 2008 Feb; 30(1):1-4. PubMed ID: 18223455
[TBL] [Abstract][Full Text] [Related]
39. [A study of the dosage and efficacy of entecavir for treating hepatitis B virus].
Yao GB; Zhang DF; Wang BE; Xu DZ; Zhou XQ; Lei BJ
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):484-7. PubMed ID: 16042878
[TBL] [Abstract][Full Text] [Related]
40. Changing landscape of antiviral resistance management in chronic hepatitis B.
Nguyen T; Locarnini S; Desmond P
J Gastroenterol Hepatol; 2008 Sep; 23(9):1314-7. PubMed ID: 18853991
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
